CX3CR1 identifies PD-1 therapy-responsive CD8+ T cells that withstand chemotherapy during cancer chemoimmunotherapy

Авторы
Yan Y. 1 , Adjei A.A. 3, 1 , Mansfield A.S. 1 , Markovic S.N. 1 , Dronca R.S. 1 , Cao S. 2 , Liu X. 2 , Harrington S.M. 2 , Bindeman W.E. 2 , Dong H. 2, 7 , Jang J.S. 4 , Jen J. 4 , Li Y. 5 , Chanana P. 5 , Park S.S. 6
Journal
JCI Insight
Номер выпуска
8
Язык
English
Статус
Published
DOI
10.1172/JCI.INSIGHT.97828
Том
3
Год
2018
Организации
  • 1 Division of Medical Oncology
  • 2 Mayo Clinic Cancer Center Early Therapeutic Program
  • 3 Department of Urology
  • 4 Department of Immunology|Mayo Clinic
  • 5 Mayo Clinic Center of Individualized Medicine
  • 6 Department of Biomedical Statistics and Informatics
  • 7 Department of Radiation Oncology
Цитировать
ГОСТ MLA RIS BibTex
Поделиться

Другие записи